NCT01118351 2019-05-01
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
Case Comprehensive Cancer Center
University of Michigan
University of Michigan Rogel Cancer Center